The nickel-dependent enzyme urease is a virulence factor for a large number of critical human pathogens, making this enzyme a potential target of therapeutics for the treatment of resistant bacterial infections. In the search for novel urease inhibitors, five selected coordination and organometallic Au(III) compounds containing N^N or C^N and C^N^N ligands were tested for their inhibitory effects against Canavalia ensiformis (jack bean) urease. The results showed potent inhibition effects with IC50 values in the nanomolar range. The 2.14-Å resolution crystal structure of Sporosarcina pasteurii urease inhibited by the most effective Au(III) compound [Au(PbImMe)Cl2]PF6 (PbImMe = 1-methyl-2-(pyridin-2-yl)-benzimidazole) reveals the presence of two Au ions bound to the conserved triad αCysγββ/αHisγβγ/αεetγ67. The binding of the Au ions to these residues blocks the movement of a flap, located at the edge of the active site channel and essential for enzyme catalysis, completely obliterating the catalytic activity of urease. Overall, the obtained results constitute the basis for the design of new gold complexes as selective urease inhibitors with future antibacterial applications.
Several metals and metal-based compounds have been used for centuries as anti-infective agents on a simple empirical basis with some appreciable results. For instance, gold cyanide was proposed by Koch as an antitubercular agent in the pioneering times of modern pharmacology. 1 Since then, remarkable progress has been made on the development of gold complexes as therapeutic agents, starting from the anti-arthritis agent auranofin (AF) [2, 3, 4 ,6-tetra-o-acetyl-L-thio--D-glucopyranosato-S-(triethyl-phosphine)Au(I)]. Recently, this drug is receiving increasing attention for its potential to be repurposed as anticancer, antiparasitic and antibacterial agent, [2] [3] [4] leading to the development of novel gold-based antibacterial agents acting as specific inhibitors of several important enzymes. [4] [5] [6] [7] [8] [9] [10] [11] [12] For example, a family of Au(I)-based phosphine complexes were tested and compared with AF toward a representative panel of pathogens that included Gram-positive, Gram-negative and Candida strains, 13 and showed activity on Gram-positive strains. More recently, organometallic Au(I) N-heterocyclic carbene (NHC) complexes were reported as effective antibacterial agents towards Gram-positive bacteria. 9, [14] [15] [16] Despite an increasing number of studies, the precise mechanism of the antimicrobial action of Au(I) complexes and their biomolecular targets are unknown. Due to the reported inhibition on the mammalian seleno-enzyme thioredoxin reductase (TrxR) by AF and Au(I) NHCs complexes, with formation of a stable Au-selenol adduct at the active site of the protein, 17 it was hypothesized that this enzyme could also be responsible for the observed antibacterial effects. However, the bacterial TrxRs lack the 'aurophilic' selenol active site, 18 and this may account for the reduced affinity of Au(I) binding with respect to mammalian TrxRs. Within this framework, only rare studies on the possible use of Au(III) complexes as targeted inhibitors of bacterial enzymes have appeared so far. For example, phosphorous dendrimers bearing iminopyridino-end groups coordinating to Au(III) ions were reported to inhibit the growth of both Gram-positive and Gram-negative bacterial strains. 19 Moreover, moderate antibacterial activity of Au(III) complexes with different L-histidinecontaining dipeptides was described, 20 but no mechanistic investigation was conducted to rationalize the observed biological effects. In general, Au(III) complexes have less affinity and selectivity for TrxRs binding, 21 while they appear to target different types of mammalian proteins, including zinc finger proteins, 22, 23 water/glycerol channels, 24, 25 the proteasome 26 and phosphatases, 27 among others. An emerging target for bacterial infections is urease (urea amidohydrolase, E.C. 3.5.1.5), a nickel-dependent enzyme found in a large variety of organisms [28] [29] [30] [31] [32] and featuring a bimetallic Ni(II)-containing reaction site. 29, 30, 32 Urease is involved in the global nitrogen cycle, catalyzing the rapid hydrolytic decomposition of urea to eventually yield ammonia and carbonate, 33, 34 consequently causing a pH increase that has negative effects both on agriculture 35 and human health. 36 For instance, ten of the twelve antibiotic-resistant priority pathogens listed in 2017 by the World Health Organization (WHO) are ureolytic bacteria for which urease is a virulence factor. 37 Moreover, mixed species infections are more difficult to treat because of an increased tolerance to antimicrobials. 36 The general high significance given by the WHO to the antimicrobial-resistance priority, supported by the Global Antimicrobial Resistance Surveillance System (GLASS), 38 imposes urease to the attention of the researchers as a target to develop new drugs for the treatment of important bacterial infections acting as a threat to public health worldwide. Moreover, the very high structure conservation of ureases from plants and bacteria warrants the possibility to extend the results obtained in the pharmaceutical and medical applications to the agro-environmental field, for which an excessive urease activity also represents a negative aspect. [28] [29] [30] [31] [32] A large number of urease inhibitors such as -mercapto-ethanol, 39 phosphate, 40 sulfite, 41 fluoride, 42 as well as hydroxamic, 43 citric 44 and boric 45 acids, 1,4-benzoquinone 46 and catechol, 47 diamido-phosphate and monoamido-thiophosphate originated, respectively, by urease-catalyzed hydrolysis of phenylphosphorodiamidate (PPD) 48 or N-(n-butyl)thiophosphoric triamide (NBPT) 49 have been studied and the structural details of their modes of action have been elucidated. Additionally, metal ions such as Co(II), Ni(II), Cu(II), Zn(II), Cd(II), Pb(II), Hg(II) and Ag(I) are also good urease inhibitors. [50] [51] [52] Within this context, the efficacy of Ag(I) as a urease inactivator has been recently rationalized by the structural determination of its adduct with Sporosarcina pasteurii (S. pasteurii) urease (SPU). 53 Ag(I) deactivates urease by forming a dinuclear cluster of two Ag(I) ions bound to the largely conserved triad αCys322/αHis323/αMet367, thus blocking the movement of a structural motif (mobile flap), essential for urease activity, consequently inhibiting the catalytic activity of the enzyme. Remarkably, no Au compound has ever been tested as urease inhibitor so far. We report here on a urease inhibition activity screening of selected Au(III) complexes with bidentate N-donor ligands or cyclometalated C^N and C^N^N scaffolds (compounds 1-5, Figure 1 ). In detail, two coordination complexes with (pyridyl)benzimidazole type ligands -[Au(PbIm)Cl2] (1) (PbIm = 2-(pyridin-2-yl)-benzimidazole) 54 and [Au(PbImMe)Cl2]PF6 (2) (PbImMe = 1-methyl-2-(pyridin-2-yl)-benzimidazole), 24 respectively, were selected. Moreover, three organometallic Au(III) compounds featuring the C^N cyclometalated 2-benzylpyridine (py b -H) ligand (3) 55 and N-phenylpyridin-2-amine (phepy a ) ligand (4), 56 as well as the tridentate C^N^N ligand 6-(1,1-dimethylbenzyl)-β,β'-bipyridine (bipy dmb ) (5) 57 were also examined. The compounds were synthesized according to previously reported procedures. 24, [54] [55] [56] [57] The Au(III) compounds were tested for their inhibitory effects against Canavalia ensiformis (jack bean) urease (JBU) in vitro, and the structure of the adduct obtained upon incubation of compound 2 with SPU was determined by X-ray diffraction crystallography. Model coordinates and structure factors were deposited in the Protein Data Bank (PDB) under the accession code 6I9Y. Kinetics of JBU inhibition with Au(III) compounds. The efficiency of urease inhibition by compounds 1-5 was tested by incubating JBU for 1 h in the presence of increasing concentrations of the different compounds, in order for the enzyme-inhibitor complex to reach a steady-state condition. Subsequently, the activity of urease was determined (see Supplementary Information for experimental details). Plots of the reaction rate after incubation, normalized vs. the reaction rate of the nontreated enzyme, as a function of inhibitor concentration, show a sigmoidal distribution (Figure 1 -SI). A fit of the data to the canonical equation to obtain the inhibitor concentrations bringing about 50% inactivation of the enzyme (IC50) yielded similar values for compounds 1-5, in the low-nanomolar concentration range ( Table 1 ). The most potent inhibitor is the cationic coordination complex 2, while the bidentate neutral N^N compound 1 and the cyclometalated C^N derivatives 3 and 4 are ca. 2-fold less active. This observation suggests that non-covalent gold complex-urease adduct formation, involving electrostatic interactions between the two partners, may be instrumental to facilitate Au(III) coordinative binding. 58 In line with previous studies on the reactivity of cyclometalated complexes with proteins, 59 the Au(III) C^N^N complex 5 is the least efficient of the series. Notably, the urease inhibition strength of the Au(III) compounds is comparable to that observed for other metal ions (namely, Hg(II), Ag(I) and Cu(II)) and two-three orders of magnitude greater than in the case of Zn(II), Cd(II), Ni(II), Pb(II) and Co(II). [50] [51] [52] However, the advantage of using coordination or organometallic compounds allows the fine-tuning of the properties of the respective Au(III) complexes, reduces their speciation in aqueous solution, and allows for further optimization of the selectivity properties for a certain target.
Table 1. Values of IC50 for the inhibition of jack bean urease (JBU) by compounds 1-5 in Figure 1

Compound
Type of ligand IC50 (nM) X-ray structure of SPU inactivated by a selected coordination Au(III) complex. The X-ray crystal structure of SPU cocrystallized in the presence of the best urease inhibitor, specifically the cationic Au(III) compound 2 (PDB code 6I9Y, see Supplementary Information for experimental details; data collection, processing and refinement statistics for Au-inhibited SPU are provided in Table 1 -SI) shows the well-described heteropolymeric nature of S. pasteurii urease, consisting of an (α )3 quaternary structure. The similarity of the protein scaffold with respect to native urease (PDB code 4CEU) 42 is confirmed by the RεSD between their Cα atoms (0.29, 0.25 and 0.β0 Å for the α, and subunits, respectively). A more detailed analysis of the Cα RMSD (Figure 2 -SI) reveals that the and subunits show a largely invariant backbone with respect to that of the native enzyme, whereas three portions of the α subunit, containing the Ni-bound active-site, are affected by significantly larger displacements: i) a region including residues 390-400, located on a surface patch showing a large conformational variability among the SPU structures determined so far, with RMSD values up to ca. 0.9 Å, ii) a region including residues 310-340, which corresponds to the mobile helix-turn-helix motif (mobile flap) responsible for the substrate access into the active site of urease, with RMSD up to ca. 1.4 Å, and iii) the region including residues 548-555, which forms a solvent exposed loop at the C-terminal portion of the α subunit, with RMSD up to ca. 1.2 Å. The overall framework of the Ni-containing active site region of the refined model is highly conserved with respect to the native enzyme, 42 as revealed by the well-defined electron density represented in Figure 2 . are also not perturbed in the presence of the inhibitor. The distances and angles around the Ni(II) ions in the SPU inhibited by compound 2 are largely indistinguishable from those observed in native and Ag(I)-inactivated SPU structures 53 (Table 2-SI) . The unbiased omit electron density map reveals two additional spherical electron densities located in the vicinity of the mobile flap, around the αCysγββ thiol, the αHisγβγ imidazole, and the αεetγ67 thioether functionalities ( Figure 3A) . The strong anomalous difference Fourier electron density maps associated to those 2Fo-Fc electron densities suggested the presence of two Au atoms in this region ( Figure 3A) . The coordination environment around the two Au atoms bound to the His-Cys-Met triad ( Figure 3A and 3B) involves His323 N and to Cys322 Sfor Au(1), and Cys322 S and Met367 S for Au(2) (Figure 3B ; all distances and angles around the Au atoms are reported in Table 3 -SI). The two Au ions are bridged by Cys322 S and are separated by 3.27 Å. The occupancy of the gold atoms is 0.85. Carbon, nitrogen, oxygen, nickel and gold atoms are light grey, blue, red, green and dark grey, respectively.
The quasi-linear geometric arrangement of the ligands is compatible with the presence of two Au(I) ions. This conclusion is also supported by previously reported electrochemical studies of compound 2, which features a reduction potential for the Au III / I reduction process Ered = -0.33 V, 24 demonstrating the possibility for the complex to undergo reduction in biological environment. The short Au ••• Au distance (3.27 Å), the small Au(1) -αCys322 S -Au(2) angle (73.2°) and the slight distortion of the αHis323 N -Au(1) -αCys322 S and αCys322 S -Au(2) -αMet367 S angles (166.4° and 159.5°, respectively), caused by a bowing effect of the two Au atoms towards each other, are strong indications of the presence of an aurophilic interaction between the two Au(I) ions. 60 A third electron density was observed close to αCys555 S in the C-terminal portion of the α chain, also featuring a strong anomalous signal suggesting the presence of a third Au atom in that region. This Au(3) atom resides in a position 25-27 Å distant from the Ni(II) ions in the active site, with no evident influence on the catalytic mechanism. The oxidation state of this atom cannot be established with certainty based on the coordination geometry, because no electron density clearly attributable to ligands other than the side chain thiol sulfur atom can be observed, even though the presence of additional ligands, such as disordered water molecules, cannot be excluded. The protein backbone of urease in the vicinity of the active site flap is strongly affected by the presence of the two Au ions, compared to the structure of the native enzyme (Figure 4) , in a similar manner to that of Ag(I)-inhibited urease. 53 Specifically, the region around the Au-binding αCysγββ and αHisγβγ, residues belonging to the mobile flap, features RMSD values for the backbone Cα atoms with respect to the corresponding atoms of native SPU that are significantly larger than the average for the unbound enzyme (Figure 2 -SI). The thiolate S atom of αCysγββ and the imidazole ring of αHisγβγ are shifted by ca. 2.3 Å and 1.2 Å, respectively, in order to coordinate the two Au ions (Figure 4 ). The Au (2) ion also provides the establishment of a covalent bridge between the mobile flap, with αCysγββ and αHisγβγ, and the more rigid portion of the protein that hosts αεetγ67, with its S shifted by 0.γ Å (Figure 3 ). Overall, we have shown here that the Au(III) complexes 1-5 are able to potently inhibit urease. Moreover, we have also structurally characterized by X-ray diffraction, for the first time, the adduct of Au ions with essential residues in the vicinity of the urease active site, elucidating the mechanism of inhibition at a molecular level. In the case of coordination compounds with bidentate N^N ligands, the binding directly involves residues likely to impair the enzymatic mechanism via alterations of the overall protein structure. The lack of the organic ligand in the crystal structure of SPU inhibited by compound 2, leaving only two naked Au ions bound to the conserved Cys-His-Met triad, suggests the presence of several successive steps of ligand substitutions and metal reduction leading to the final structure observed in the solid state. As observed for previously reported Au(III)/protein adducts, this type of compounds favors exchange of the original ligands and further possible reduction to Au(I) species. [61] [62] [63] It is worth mentioning that so far only a few X-rays structures of gold complexes (Au(I) and Au(III)) with proteins have been reported, 64 where these metal ions bind to Cys, 65 66 Lys, 67 or His residues. 68 Further studies are necessary to validate the binding mode of the cyclometalated Au(III) complexes to urease. In this case, retention of the cyclometalated ligands may be envisaged upon protein adduct formation, 23 which would be essential to design urease-targeted inhibitors. Finally, our results hold promise for the screening of the antibacterial properties of Au(III) complexes in ureolytic microorganisms, including Mycobacterium tuberculosis, Helicobacter pylori, Yersinia pestis and Cryptococcus neoformans.
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